Organization type

  • Academic research institution
  • Hospital

Early phases

  • Biomarker identification

Screening

  • Assay development
    • In vitro screening models
  • Chemical libraries
    • Natural product extracts: plants, microbial, animal (invertebrates, insects)
    • Small molecules (including natural product, DNA encoded libraries and fragment libraries)
  • Screening and high throughput screening using small molecules (including natural product, DNA encoded libraries and fragment libraries)

Optimization phases

  • In vitro cellular and organotypic 3D models (including assay/model development and testing)
  • Preclinical phase (including assay/model development and testing)(non-regulatory and regulatory)

Functional areas

  • Artificial intelligence
  • Compound management

Terapeutic areas

  • Nervous Central System